208 related articles for article (PubMed ID: 9315031)
1. Clinical and molecular aspects of Gaucher disease in New Zealand.
Woodfield MJ; Woodfield DG; Winship IM
N Z Med J; 1997 Aug; 110(1050):316-9. PubMed ID: 9315031
[TBL] [Abstract][Full Text] [Related]
2. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of 28 Gaucher disease patients: the Australasian experience.
Lewis BD; Nelson PV; Robertson EF; Morris CP
Am J Med Genet; 1994 Jan; 49(2):218-23. PubMed ID: 8116672
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.
Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C
Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027
[TBL] [Abstract][Full Text] [Related]
5. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.
Zimran A; Horowitz M
Am J Med Genet; 1994 Mar; 50(1):74-8. PubMed ID: 8160756
[TBL] [Abstract][Full Text] [Related]
6. Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations.
Alfonso P; Cenarro A; Pérez-Calvo JI; Giralt M; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(5):882-91. PubMed ID: 11783951
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
[TBL] [Abstract][Full Text] [Related]
8. Gaucher disease in Spanish patients: analysis of eight mutations.
Cormand B; Vilageliu L; Burguera JM; Balcells S; Gonzàlez-Duarte R; Grinberg D; Chabás A
Hum Mutat; 1995; 5(4):303-9. PubMed ID: 7627184
[TBL] [Abstract][Full Text] [Related]
9. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
[TBL] [Abstract][Full Text] [Related]
10. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
[TBL] [Abstract][Full Text] [Related]
11. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value.
Boot RG; Hollak CE; Verhoek M; Sloof P; Poorthuis BJ; Kleijer WJ; Wevers RA; van Oers MH; Mannens MM; Aerts JM; van Weely S
Hum Mutat; 1997; 10(5):348-58. PubMed ID: 9375849
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations.
Kolodny EH; Firon N; Eyal N; Horowitz M
Am J Med Genet; 1990 Aug; 36(4):467-72. PubMed ID: 2117855
[TBL] [Abstract][Full Text] [Related]
13. Identification of six new Gaucher disease mutations.
Beutler E; Gelbart T; West C
Genomics; 1993 Jan; 15(1):203-5. PubMed ID: 8432537
[TBL] [Abstract][Full Text] [Related]
14. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
[TBL] [Abstract][Full Text] [Related]
15. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
[TBL] [Abstract][Full Text] [Related]
16. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
Sidransky E; Bottler A; Stubblefield B; Ginns EI
Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
[TBL] [Abstract][Full Text] [Related]
19. A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease.
Cormand B; Díaz A; Grinberg D; Chabás A; Vilageliu L
Blood Cells Mol Dis; 2000 Oct; 26(5):409-16. PubMed ID: 11112377
[TBL] [Abstract][Full Text] [Related]
20. Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.
Park JK; Orvisky E; Tayebi N; Kaneski C; Lamarca ME; Stubblefield BK; Martin BM; Schiffmann R; Sidransky E
Pediatr Res; 2003 Mar; 53(3):387-95. PubMed ID: 12595585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
